| Item Type | Name |
|
Concept
|
Incidence
|
|
Academic Article
|
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
|
|
Academic Article
|
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.
|
|
Academic Article
|
Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.
|
|
Academic Article
|
Statin use and sex-specific stroke outcomes in patients with vascular disease.
|
|
Academic Article
|
Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trial.
|
|
Academic Article
|
Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV.
|
|
Academic Article
|
Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
|
|
Academic Article
|
Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.
|
|
Academic Article
|
Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.
|
|
Academic Article
|
Premature release of data from clinical trials of ezetimibe.
|
|
Academic Article
|
Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: a pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY.
|
|
Academic Article
|
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.
|
|
Academic Article
|
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.
|
|
Academic Article
|
Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI.
|
|
Academic Article
|
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.
|
|
Academic Article
|
Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial.
|
|
Academic Article
|
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.
|
|
Academic Article
|
Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).
|
|
Academic Article
|
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction.
|
|
Academic Article
|
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes.
|
|
Academic Article
|
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.
|
|
Academic Article
|
Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions.
|
|
Academic Article
|
Tooth loss is independently associated with poor outcomes in stable coronary heart disease.
|
|
Academic Article
|
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction.
|
|
Academic Article
|
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.
|
|
Academic Article
|
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
|
|
Academic Article
|
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials.
|
|
Academic Article
|
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
|
|
Academic Article
|
Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).
|
|
Academic Article
|
Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients.
|
|
Academic Article
|
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10?854 patients from the CHAMPION PHOENIX trial.
|
|
Academic Article
|
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.
|
|
Academic Article
|
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
|
|
Academic Article
|
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
|
|
Academic Article
|
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
|
|
Academic Article
|
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.
|
|
Academic Article
|
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
|
|
Academic Article
|
Towards a new order in cardiovascular medicine: re-engineering through global collaboration.
|
|
Academic Article
|
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy.
|
|
Academic Article
|
Association Between Current and Future Annual Hospital Percutaneous Coronary Intervention Mortality Rates.
|
|
Academic Article
|
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.
|
|
Academic Article
|
Incidence of Myocardial Infarction Types in Patients Treated With Ticagrelor in the THEMIS Trial.
|
|
Academic Article
|
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial.
|